Why the study?
Does virus serology accurately diagnose myocardial viral infection compared to endomyocardial biopsy in patients with suspected myocarditis?
Does virus serology accurately diagnose myocardial viral infection compared to endomyocardial biopsy in patients with suspected myocarditis?
Virus serology has no diagnostic relevance for myocardial infection in suspected myocarditis, reinforcing endomyocardial biopsy as the gold standard.
Answers are grounded in this paper and cite their sources.
Serology's low sensitivity versus EMB cautions against routine use; leaves open its adjunctive value pending prospective validation.
AIMS: Serological analyses of viral infection in suspected myocarditis are still widely used, although convincing evidence for their value is lacking. We determined prospectively the diagnostic value of virus serology in comparison with endomyocardial biopsy (EMB) including viral genome detection and immunohistochemistry in patients with clinically suspected myocarditis. METHODS AND RESULTS: Virus serology and state-of-the-art evaluation of EMB were performed in 124 patients (age 40 ± 15 years) with suspected myocarditis. Endomyocardial biopsy was studied for inflammation with histological and immunohistological criteria. The viral genome was detected in the myocardium by polymerase chain reaction. Acute viral infection with enterovirus, adenovirus, parvovirus B19, cytomegalovirus, human herpesvirus, and Epstein-Barr virus was diagnosed by IgM or IgA in the initial sample or IgG seroconversion in the follow-up sample. Immunohistological signs of inflammation were present in 54 patients. The viral genome was detected in the myocardium of 58 patients (47%). In 20 patients (16%), acute viral infection was diagnosed by serology. Only in 5 out of 124 patients (4%), there was serological evidence of an infection with the same virus that was detected by EMB. Sensitivity and specificity of virus serology were 9 and 77%, respectively. The positive predictive value was 25% and the negative predictive value was 49%. The lack of correlation between serology and EMB remained also for patients with biopsy-proven myocarditis and patients with time from initial symptoms to EMB procedure of ≤1 month. CONCLUSIONS: For patients with suspected myocarditis, virus serology has no relevance for the diagnosis of myocardial infection. Endomyocardial biopsy remains the gold standard in the diagnostic of viral myocarditis.
No takes yet. Share an insight, caveat, or question.
Mahfoud et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: